Eastern Bank’s Protara Therapeutics TARA Stock Holding History

Eastern Bank’s Portfolio TARA Stock Details TARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-71	Closed	-$271	–	1137
2026 Q2	$271	Buy	+71	New	+$338	﹤0.01%	1023

Other funds holding TARA

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Walleye Capital New York $109B AUM 29.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Eastern Bank's TARA Position: Q3 2026 in Review

Eastern Bank sold out of Protara Therapeutics (TARA) in Q3 2026, closing a stake of 71 shares — an estimated $271 sold.

Eastern Bank first reported a position in TARA in Q2 2026 and held it in 1 quarter. The position peaked at $271 in Q2 2026. 71 funds tracked by Wall St. Rank hold TARA as of Q3 2026.

Eastern Bank reported no remaining Protara Therapeutics position as of Q3 2026 after selling out during the quarter.
Eastern Bank sold 71 Protara Therapeutics shares in Q3 2026, an estimated $271.
Eastern Bank first reported a position in Protara Therapeutics in Q2 2026 and held it in 1 quarter.
Eastern Bank's Protara Therapeutics position peaked at $271 in Q2 2026.
71 funds tracked by Wall St. Rank held Protara Therapeutics as of Q3 2026.

Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.